IOVA Iovance Biotherapeutics, Inc. - Common Stock
$7,62
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$2–$8
98% of range
Analystenbewertung
BUY
15 analysts
Kursziel
$9
+21% upside
P/E (TTM)
-7.0
ROE
-56.0%
Nettogewinnmarge
-148.4%
Über Iovance Biotherapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
Iovance Biotherapeutics, Inc. is a biopharmaceutical based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
Mehr lesen
Iovance Biotherapeutics, Inc. is a biopharmaceutical based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
## History
The company was founded in 2007 as Genesis Biopharma. In 2013, Lion merged with Genesis Biopharma аnd became Lion Bio Pharma, which was then rebranded to Iovance in 2017.
In 2024, the US FDA gave accelerated approval to Lifileucel, marketed under the brand name Amtagvi, the company's tumor-infiltrating lymphocyte drug for the treatment of unresectable or metastatic melanoma.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
IOVA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$7.62
Marktkapitalisierung
$3.14B
P/E (TTM)
-7.0
EPS (TTM)
$-1.09
Umsatz (TTM)
$264M
Dividendenrendite
—
ROE
-56.0%
Verschuldungsgrad
0.0
52W-Spanne
$2 – $8
IOVA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$264M
2016-12-31
→
2025-12-31
EPS
$-1.09
2019-12-31
→
2025-12-31
Freier Cashflow
$-336M
2016-12-31
→
2025-12-31
Margen
-148.4%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
IOVA
Peer-Median
P/E (TTM)
-7.0
—
P/S (TTM) (K/V (TTM))
11.9
18.3
P/B (K/B)
4.5
3.3
EV / EBITDA
-7.3
—
Price / FCF (Kurs / FCF)
-9.3
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
IOVA
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-153.1%
—
Net Profit Margin (Nettogewinnmarge)
-148.4%
-180.4%
ROA
-42.9%
-36.2%
ROE
-56.0%
-43.7%
ROIC
-57.4%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
IOVA
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.0
—
Current Ratio (Liquiditätsgrad)
3.2
9.7
Quick Ratio
2.7
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
IOVA
Peer-Median
Revenue YoY (Umsatz YoY)
60.6%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
IOVA
Peer-Median
IOVA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
15 Analysten
- Starker Kauf 3 20,0%
- Kauf 9 60,0%
- Halten 3 20,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
9 Analysten · 2026-08-19
Median
$9.00
Jetzt
$7.62
Tief
$4.00
Hoch
$14.00
Median-Ziel
$9.00
+18,2%
Mittelwert-Ziel
$9.22
+21,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.03%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.11 | $-0.13 | 0.02% |
| 31. März 2026 | $-0.19 | $-0.15 | -0.04% |
| 31. Dezember 2025 | $-0.18 | $-0.18 | -0.00% |
| 30. September 2025 | $-0.25 | $-0.26 | 0.01% |
| 30. Juni 2025 | $-0.33 | $-0.29 | -0.04% |
| 31. März 2025 | $-0.36 | $-0.24 | -0.12% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $264M | $164M | $1M | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $173M | $93M | $1M | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $300M | $276M | $333M | $295M | $259M | $202M | $166M | $100M | $72M | $27M | $15M | $4M | |
| SG&A Expense | $152M | $152M | $106M | $104M | $84M | $60M | $41M | $28M | $21M | $27M | $12M | $8M | |
| Operating Expenses | $667M | $559M | $462M | $399M | $343M | $262M | $207M | $128M | $93M | $54M | $28M | $12M | |
| Operating Income | $-403M | $-395M | $-461M | $-399M | $-343M | $-262M | $-207M | $-128M | $-93M | $-54M | $-28M | $-12M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $-5.7K | |
| Interest Income | $10M | $20M | $13M | $3M | $451.0K | $2M | $9M | $5M | $813.0K | $745.0K | $200.0K | $6.0K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $200.0K | $6.0K | |
| Pretax Income | $-393M | $-375M | $-448M | $-396M | $-342M | · | · | · | · | · | · | · | |
| Income Tax | $-2M | $-3M | $-3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-391M | $-372M | $-444M | $-396M | $-342M | $-260M | $-198M | $-124M | $-92M | $-53M | $-28M | $-12M | |
| EPS (Basic) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | · | · | · | · | · | |
| EPS (Diluted) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | · | · | · | · | · | |
| Shares (Basic) | 357,345 | 289,877 | 235,131 | 159,259 | 153,406 | 138,301 | 124,336 | · | · | · | · | · | |
| Shares (Diluted) | 357,345 | 289,877 | 235,131 | 159,259 | 153,406 | 138,301 | 124,336 | · | · | · | · | · | |
| EBITDA | $-390M | $-383M | $-449M | $-390M | $-340M | $-261M | $-206M | $-128M | $-93M | $-54M | $-28M | · |
Bilanz 28
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $163M | $116M | $115M | $232M | $78M | $67M | $14M | $82M | $145M | $107M | $34M | $45M | |
| Short-term Investments | $134M | $208M | $165M | $240M | $426M | $562M | $293M | $386M | $0 | $60M | $70M | $0 | |
| Receivables | $82M | $69M | $151.0K | · | · | · | · | · | · | · | · | · | |
| Inventory | $52M | $52M | $10M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $12M | $12M | $17M | $7M | $4M | $7M | $9M | $7M | $4M | $3M | $277.0K | $66.0K | |
| Current Assets | $443M | $457M | $308M | $479M | $508M | $636M | $316M | $475M | $149M | $170M | $104M | $45M | |
| PP&E (Net) | $131M | $109M | $114M | $105M | $101M | $59M | $9M | $3M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $180M | $145M | $142M | $122M | $110M | $65M | $13M | $7M | $5M | $4M | $3M | $2M | |
| Accum. Depreciation | $49M | $36M | $28M | $17M | $9M | $6M | $4M | $4M | $3M | $2M | $1M | $104.0K | |
| Intangibles | $279M | $282M | $229M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $369.0K | $270.0K | $189.0K | $2M | $13M | $3M | $3M | $4M | $0 | · | · | |
| Total Assets | $913M | $910M | $780M | $664M | $777M | $768M | $345M | $481M | $155M | $172M | $106M | $47M | |
| Accounts Payable | $22M | $28M | $33M | $27M | $27M | $14M | $16M | $3M | $1M | $863.0K | $958.0K | $1M | |
| Accrued Liabilities | $111M | $82M | $69M | $52M | $57M | $35M | $16M | $12M | $8M | $4M | $672.0K | $328.0K | |
| Short-term Debt | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $138M | $122M | $110M | $91M | $89M | $55M | $39M | $14M | $10M | $5M | $2M | $2M | |
| Capital Leases | $44M | $44M | $67M | $72M | $65M | $45M | $4M | $0 | · | · | · | · | |
| Deferred Tax | $32M | $32M | $17M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $12M | $2M | $230.0K | · | · | · | · | |
| Total Liabilities | $215M | $200M | $196M | $164M | $156M | $112M | $46M | $15M | $10M | · | · | · | |
| Total Debt | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $17.0K | $13.0K | $11.0K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $3.0K | $3.0K | $2.0K | $2.0K | |
| Paid-in Capital | $3.46B | $3.10B | $2.59B | $2.07B | $1.79B | $1.49B | $869M | $839M | $395M | $324M | $208M | $121M | |
| Retained Earnings | $-2.78B | $-2.38B | $-2.01B | $-1.57B | $-1.17B | $-830M | $-571M | $-373M | $-249M | $-157M | $-104M | $-77M | |
| AOCI | $16M | $-1M | $3M | $-902.0K | $-601.0K | $19.0K | $220.0K | $-42.0K | $0 | $29.0K | $48.0K | $0 | |
| Stockholders' Equity | $699M | $710M | $585M | $500M | $622M | $656M | $299M | $466M | $145M | $167M | $104M | $45M | |
| Liabilities + Equity | $913M | $910M | $780M | $664M | $777M | $768M | $345M | $481M | $155M | $172M | $106M | $47M | |
| Shares Outstanding | 411,938,061 | 305,252,194 | 256,135,715 | 187,812,072 | 157,004,742 | 147,874,917 | 126,411,808 | 123,415,576 | 73,164,914 | 62,248,074 | 48,547,720 | 33,750,188 |
Cashflow 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $11M | $12M | $9M | $3M | $1M | $1M | $956.0K | $952.0K | $978.0K | $999.0K | $88.0K | |
| Stock-based Comp | $62M | $110M | $63M | $84M | $70M | $41M | $24M | $20M | $12M | $19M | $9M | $4M | |
| Deferred Tax | $-2M | $-3M | $-3M | · | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $23M | $26M | $10M | $0 | · | · | · | · | · | · | · | · | |
| Restructuring | $5M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $16M | $-100M | $12M | $10M | $41M | $12M | $13M | · | · | · | · | · | |
| Operating Cash Flow | $-302M | $-353M | $-362M | $-293M | $-228M | $-205M | $-159M | $-101M | $-79M | $-33M | $-18M | $-9M | |
| CapEx | $34M | $11M | $22M | $20M | $38M | $47M | $7M | $1M | $1M | $2M | $1M | $2M | |
| Investing Cash Flow | $47M | $-96M | $-155M | $256M | $132.0K | $-318M | $90M | $-386M | $59M | $9M | $-71M | · | |
| Debt Issued | · | · | · | · | $1M | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | $1M | · | · | · | · | · | · | · | |
| Stock Issued | $306M | $397M | $463M | $190M | $203M | $567M | · | $399M | $54M | $96M | $68M | $32M | |
| Net Stock Activity | $306M | $397M | $463M | $190M | $203M | $567M | · | $399M | $54M | $96M | $68M | · | |
| Financing Cash Flow | $301M | $391M | $463M | $190M | $239M | $576M | $6M | $424M | $59M | $97M | $78M | · | |
| Net Change in Cash | $47M | $-59M | $-57M | $154M | $11M | · | · | $-63M | $39M | $73M | $-11M | $25M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Free Cash Flow | $-336M | $-364M | $-384M | $-313M | $-266M | $-252M | $-166M | $-102M | $-80M | $-34M | $-20M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -153.1% | -240.9% | -38735.0% | · | · | · | · | · | · | · | · | · | |
| Net Margin | -148.4% | -226.8% | -37345.4% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -149.2% | -228.6% | -37638.0% | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -148.2% | -233.6% | -37762.1% | · | · | · | · | · | · | · | · | · | |
| ROA | -42.9% | -44.0% | -61.5% | -54.9% | -44.3% | -46.6% | -47.9% | -38.9% | -56.3% | -38.1% | -36.4% | · | |
| ROE | -56.0% | -50.2% | -70.6% | -88.6% | -51.9% | -37.9% | -60.4% | -34.3% | -58.9% | -39.0% | -37.2% | · | |
| ROIC | -57.4% | -55.2% | -78.2% | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.7 | 2.8 | 5.2 | 5.7 | 11.6 | 8.1 | 33.0 | 15.1 | 34.1 | 63.8 | · | |
| Quick Ratio | 2.7 | 3.2 | 2.5 | 5.2 | 5.7 | 11.5 | 7.9 | 32.5 | 14.7 | 33.5 | 51.4 | · | |
| Debt / Equity | 0.0 | · | · | · | · | · | · | · | · | · | · | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.0 | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Inventory Turnover | 3.4 | 4.0 | 2.1 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 3.5 | 4.7 | 15.7 | · | · | · | · | · | · | · | · | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 60.6% | 13699.0% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $264M | $164M | $1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-391M | $-372M | $-444M | $-396M | $-342M | $-260M | $-198M | $-124M | $-92M | $-53M | $-28M | $-12M | |
| Market Cap | $1.12B | $2.26B | $2.08B | $1.20B | $3.00B | $6.81B | $3.50B | $1.09B | $585M | $433M | $375M | · | |
| Enterprise Value | $829M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -2.5 | -5.8 | -4.3 | -2.6 | -8.6 | -24.7 | -17.4 | · | · | · | · | · | |
| P/S | 4.3 | 13.8 | 1751.4 | · | · | · | · | · | · | · | · | · | |
| P/B | 1.6 | 3.2 | 3.6 | 2.4 | 4.8 | 10.4 | 11.7 | 2.3 | 4.0 | 2.6 | 3.6 | · | |
| P / Tangible Book | 2.7 | 5.3 | 5.9 | 2.4 | 4.8 | 10.4 | · | · | · | · | · | · | |
| P / Cash Flow | -3.7 | -6.4 | -5.8 | -4.1 | -13.1 | -33.2 | -22.0 | -10.8 | -7.4 | -13.2 | -20.4 | · | |
| P / FCF | -3.3 | -6.2 | -5.4 | -3.8 | -11.3 | -27.1 | -21.1 | -10.7 | -7.3 | -12.7 | -19.2 | · | |
| EV / EBITDA | -2.1 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -2.5 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 3.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -39.9% | -17.3% | -23.2% | -39.0% | -11.7% | -4.0% | -5.7% | · | · | · | · | · |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $99M | $71M | $87M | $67M | $60M | $49M | $74M | $59M | $31M | $715.0K | $482.0K | $469.0K | $238.0K | · | · | · | |
| Cost of Revenue | $44M | $42M | $28M | $38M | $49M | $43M | $23M | $32M | $31M | $7M | $-5M | $4M | $2M | · | · | · | |
| R&D Expense | $59M | $62M | $69M | $75M | $78M | $76M | $67M | $67M | $62M | $80M | $77M | $88M | $86M | $83M | $81M | $73M | |
| SG&A Expense | $39M | $39M | $36M | $35M | $38M | $44M | $42M | $39M | $40M | $31M | $29M | $27M | $22M | $28M | $26M | $28M | |
| Operating Expenses | $151M | $152M | $160M | $162M | $174M | $171M | $160M | $148M | $133M | $118M | $122M | $119M | $110M | $111M | $107M | $100M | |
| Operating Income | $-52M | $-81M | $-73M | $-95M | $-114M | $-121M | $-87M | $-89M | $-102M | $-118M | $-121M | $-118M | $-110M | $-111M | $-107M | $-100M | |
| Interest Income | $3M | $1M | $2M | $1M | $4M | $3M | $10M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $777.0K | |
| Pretax Income | $-49M | $-80M | $-72M | $-94M | $-110M | $-118M | $-77M | $-85M | $-99M | $-114M | $-118M | $-115M | $-107M | $-107M | $-105M | $-100M | |
| Income Tax | $-1M | $-665.0K | $184.0K | $-2M | $2M | $-2M | $2M | $-2M | $-1M | $-1M | $-2M | $-1M | $-477.0K | $0 | · | · | |
| Net Income | $-47M | $-79M | $-72M | $-91M | $-112M | $-116M | $-79M | $-84M | $-97M | $-113M | $-116M | $-114M | $-107M | $-107M | $-105M | $-100M | |
| EPS (Basic) | $-0.11 | $-0.19 | $-0.15 | $-0.25 | $-0.33 | $-0.36 | $-0.24 | $-0.28 | $-0.34 | $-0.42 | $-0.46 | $-0.46 | $-0.47 | $-0.50 | $-0.65 | $-0.63 | |
| EPS (Diluted) | $-0.11 | $-0.19 | · | · | $-0.33 | $-0.36 | $-0.24 | $-0.28 | $-0.34 | $-0.42 | $-0.46 | $-0.46 | $-0.47 | $-0.50 | $-0.65 | $-0.63 | |
| Shares (Basic) | 450,189 | 418,511 | -664,071 | 364,037 | 334,511 | 322,868 | -564,429 | 303,269 | 284,817 | 266,220 | -213,929,167 | 245,817 | 224,481 | 213,694,000 | -472,044,741 | 157,817,000 | |
| Shares (Diluted) | 450,189 | 418,511 | · | · | 334,511 | 322,868 | -564,429 | 303,269 | 284,817 | 266,220 | -213,929,167 | 245,817 | 224,481 | 213,694,000 | -472,044,741 | 157,817,000 | |
| EBITDA | $-52M | $-78M | · | $-95M | $-110M | $-118M | · | $-86M | $-99M | $-115M | · | $-115M | $-107M | $-108M | · | $-100M |
Bilanz 27
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $197M | $163M | $158M | $132M | $172M | $116M | $164M | $229M | $134M | $115M | $268M | $230M | $543M | $232M | $118M | |
| Short-term Investments | $187M | $117M | $134M | $143M | $169M | $188M | $208M | $233M | $184M | $222M | · | $94M | $21M | $83M | · | $242M | |
| Receivables | $102M | $82M | $82M | $67M | $60M | $71M | $69M | $56M | $32M | $234.0K | · | · | $33.0K | · | · | · | |
| Inventory | $56M | $58M | $52M | $52M | $50M | $66M | $52M | $39M | $28M | $18M | · | $9M | $10M | · | · | · | |
| Prepaid Expense | $9M | $13M | $12M | $10M | $12M | $16M | $12M | $7M | $10M | $11M | · | $12M | $14M | $11M | · | $10M | |
| Current Assets | $464M | $467M | $443M | $429M | $422M | $513M | $457M | $499M | $482M | $386M | · | $383M | $275M | $638M | · | $370M | |
| PP&E (Net) | $131M | $131M | $131M | $127M | $122M | $112M | $109M | $113M | $111M | $112M | · | $113M | $113M | $110M | · | $101M | |
| PP&E (Gross) | $188M | $184M | $180M | $172M | $165M | $150M | $145M | $149M | $145M | $143M | · | $138M | $135M | $129M | · | $115M | |
| Accum. Depreciation | $56M | $52M | $49M | $45M | $42M | $39M | $36M | $37M | $34M | $31M | · | $25M | $22M | $19M | · | $14M | |
| Intangibles | $264M | $269M | $279M | $285M | $296M | $285M | $282M | $307M | $295M | $294M | · | $224M | $236M | · | · | · | |
| Other Non-current Assets | $6M | $8M | $8M | $9M | $10M | $426.0K | $369.0K | $280.0K | $327.0K | $259.0K | · | $282.0K | $294.0K | $202.0K | · | $596.0K | |
| Total Assets | $916M | $926M | $913M | $905M | $907M | $967M | $910M | $991M | $964M | $870M | · | $852M | $757M | $825M | · | $546M | |
| Accounts Payable | $26M | $37M | $22M | $31M | $32M | $28M | $28M | $32M | $20M | $26M | · | $19M | $31M | $32M | · | $24M | |
| Accrued Liabilities | $78M | $88M | $111M | $87M | $89M | $85M | $82M | $75M | $62M | $46M | · | $61M | $47M | $43M | · | $48M | |
| Short-term Debt | · | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $107M | $129M | $138M | $126M | $129M | $123M | $122M | $118M | $94M | $83M | · | $91M | $89M | $87M | · | $79M | |
| Capital Leases | $43M | $44M | $44M | $45M | $45M | $44M | $44M | $66M | $69M | $72M | · | $68M | $69M | $70M | · | $72M | |
| Deferred Tax | $29M | $31M | $32M | $32M | $35M | $32M | $32M | $32M | $32M | $33M | · | $18M | $20M | · | · | · | |
| Total Liabilities | $179M | $204M | $215M | $203M | $209M | $199M | $200M | $218M | $196M | $190M | · | $178M | $179M | $158M | · | $152M | |
| Total Debt | · | $1M | · | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $19.0K | $18.0K | $17.0K | $16.0K | $14.0K | $14.0K | $13.0K | $13.0K | $12.0K | $12.0K | · | $11.0K | $9.0K | $9.0K | · | $7.0K | |
| Paid-in Capital | $3.62B | $3.56B | $3.46B | $3.39B | $3.29B | $3.26B | $3.10B | $3.06B | $2.99B | $2.81B | · | $2.58B | $2.36B | $2.34B | · | $1.86B | |
| Retained Earnings | $-2.90B | $-2.85B | $-2.78B | $-2.70B | $-2.61B | $-2.50B | $-2.38B | $-2.31B | $-2.22B | $-2.13B | · | $-1.90B | $-1.78B | $-1.68B | · | $-1.46B | |
| AOCI | $13M | $13M | $16M | $16M | $21M | $6M | $-1M | $16M | $526.0K | $116.0K | · | $-9M | $325.0K | $-126.0K | · | $-2M | |
| Stockholders' Equity | $736M | $722M | $699M | $702M | $698M | $768M | $710M | $773M | $769M | $680M | $585M | $674M | $579M | $667M | $500M | $394M | |
| Liabilities + Equity | $916M | $926M | $913M | $905M | $907M | $967M | $910M | $991M | $964M | $870M | · | $852M | $757M | $825M | · | $546M | |
| Shares Outstanding | 452,971,016 | 438,106,537 | 411,938,061 | 385,461,728 | 341,919,364 | 333,934,387 | 305,252,194 | 304,620,470 | 297,305,999 | 279,756,339 | · | 255,833,679 | 224,688,434 | 224,358,979 | · | 157,840,581 |
Cashflow 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $3M | $4M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Stock-based Comp | $12M | $11M | $12M | $12M | $15M | $23M | $31M | $31M | $30M | $17M | $14M | $16M | $17M | $16M | $20M | $20M | |
| Deferred Tax | $-1M | $-665.0K | $184.0K | $-2M | $2M | $-2M | $2M | $-2M | $-1M | $-1M | $-2M | $-1M | $-477.0K | $0 | · | $0 | |
| Amort. of Intangibles | $6M | $6M | $6M | $6M | $6M | $5M | $11M | $6M | $6M | $5M | $4M | $4M | $2M | $0 | · | $0 | |
| Restructuring | · | · | $0 | $5M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-6M | · | · | · | $-11M | · | · | · | $-28M | · | · | · | $-11M | · | · | |
| Operating Cash Flow | $-61M | $-72M | $-53M | $-79M | $-67M | $-104M | $-73M | $-59M | $-98M | $-122M | $-84M | $-84M | $-94M | $-100M | $-78M | $-64M | |
| CapEx | $5M | $7M | $9M | $11M | $7M | $6M | $4M | $2M | $442.0K | $4M | $4M | $4M | $10M | $6M | $3M | $1M | |
| Investing Cash Flow | $-74M | $11M | $775.0K | $17M | $14M | $16M | $24M | $-49M | $40M | $-112M | $-73M | $-79M | $-157M | $153M | $461.0K | $74M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Issued | $50M | $99M | $56M | $89M | $13M | $149M | $0 | $48M | $152M | $198M | $1.0K | $203M | $0 | $260M | $190M | $0 | |
| Net Stock Activity | · | $99M | · | · | · | $149M | · | · | · | $198M | · | · | · | $260M | · | · | |
| Financing Cash Flow | $49M | $94M | $56M | $88M | $13M | $143M | $2M | $42M | $153M | $194M | $962.0K | $203M | $1M | $258M | $191M | $225.0K | |
| Net Change in Cash | $-86M | $33M | $5M | $26M | $-40M | $56M | $-48M | $-65M | $94M | $-41M | $-153M | $38M | $-253M | $312M | $113M | $10M | |
| Free Cash Flow | · | $-79M | · | · | · | $-110M | · | · | · | $-126M | · | · | · | $-105M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -52.3% | -113.5% | · | -140.7% | -189.8% | -245.8% | · | -152.1% | -327.6% | -16464.6% | · | -25236.9% | -46254.6% | · | · | · | |
| Net Margin | -47.6% | -110.7% | · | -135.3% | -186.2% | -235.5% | · | -142.7% | -312.2% | -15800.8% | · | -24255.9% | -44759.7% | · | · | · | |
| Pretax Margin | -49.0% | -111.6% | · | -138.8% | -182.9% | -239.2% | · | -145.3% | -316.8% | -15997.8% | · | -24520.9% | -44960.1% | · | · | · | |
| EBITDA Margin | -52.3% | -109.5% | · | -140.7% | -184.1% | -240.1% | · | -147.0% | -318.0% | -16048.1% | · | -24618.5% | -45036.1% | · | · | · | |
| ROA | -5.2% | -8.3% | · | -9.6% | -11.9% | -12.7% | · | -9.1% | -11.3% | -13.3% | · | -16.3% | -15.6% | -14.1% | · | -14.5% | |
| ROE | -6.6% | -10.6% | · | -12.4% | -15.2% | -16.1% | · | -11.5% | -14.4% | -16.8% | · | -21.3% | -20.3% | -17.6% | · | -18.2% | |
| ROIC | -6.9% | -11.1% | · | -13.2% | -16.6% | -15.5% | · | -11.3% | -13.1% | -17.1% | · | -17.4% | -18.9% | · | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 3.6 | · | 3.4 | 3.3 | 4.2 | · | 4.2 | 5.2 | 4.6 | · | 4.2 | 3.1 | 7.3 | · | 4.7 | |
| Quick Ratio | 3.7 | 3.1 | · | 2.9 | 2.8 | 3.5 | · | 3.8 | 4.7 | 4.3 | · | 4.0 | 2.8 | 7.2 | · | 4.5 | |
| Debt / Equity | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | |
| Inventory Turnover | 0.8 | 0.7 | · | 0.9 | 1.5 | 1.2 | · | 1.7 | 1.7 | 0.8 | · | 0.9 | 0.4 | · | · | · | |
| Receivables Turnover | 1.2 | 0.9 | · | 1.1 | 1.3 | 1.4 | · | 2.1 | 2.0 | 6.1 | · | · | 14.4 | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $298M | $248M | · | $235M | $199M | $140M | · | $91M | $33M | · | · | · | · | $0 | · | $0 | |
| Net Income TTM | $-329M | $-398M | · | $-403M | $-408M | $-410M | · | $-407M | $-430M | $-441M | · | $-427M | $-413M | $-398M | · | $-377M | |
| Market Cap | $1.88B | $1.54B | · | $836M | $588M | $1.11B | · | $2.86B | $2.38B | $4.15B | · | $1.16B | $1.58B | $1.37B | · | $1.51B | |
| Enterprise Value | · | $1.23B | · | $537M | $288M | $753M | · | · | · | · | · | · | · | · | · | · | |
| P/E | · | · | · | -1.7 | -1.3 | -2.4 | · | -6.3 | -4.7 | -8.0 | · | -2.2 | -3.2 | -2.6 | · | -4.0 | |
| P/S | 6.3 | 6.2 | · | 3.6 | 3.0 | 8.0 | · | 31.5 | 73.3 | · | · | · | · | · | · | · | |
| P/B | 2.6 | 2.1 | · | 1.2 | 0.8 | 1.4 | · | 3.7 | 3.1 | 6.1 | · | 1.7 | 2.7 | 2.1 | · | 3.8 | |
| P / Tangible Book | 4.0 | 3.4 | · | 2.0 | 1.5 | 2.3 | · | 6.1 | 5.0 | 10.7 | · | 2.6 | 4.6 | 2.1 | · | 3.8 | |
| P / Cash Flow | · | -21.3 | · | · | · | -10.7 | · | · | · | -33.9 | · | · | · | -13.7 | · | · | |
| P / FCF | · | -19.5 | · | · | · | -10.1 | · | · | · | -32.8 | · | · | · | -13.0 | · | · | |
| EV / EBITDA | · | -15.7 | · | -5.7 | -2.6 | -6.4 | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | -15.6 | · | · | · | -6.9 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | 4.9 | · | 2.3 | 1.4 | 5.4 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | · | · | -60.4% | -76.2% | -42.0% | · | -16.0% | -21.1% | -12.5% | · | -45.3% | -31.7% | -38.3% | · | -24.9% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $264M | $164M | $1M | — | — |
| Betriebsgewinnmarge % | -153.1% | -240.9% | -38735.0% | — | — |
| Nettoergebnis | $-391M | $-372M | $-444M | $-396M | $-342M |
| Verwässerte EPS | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.0 | — | — | — | — |
| Liquiditätsgrad | 3.2 | 3.7 | 2.8 | 5.2 | 5.7 |
| Quick Ratio | 2.7 | 3.2 | 2.5 | 5.2 | 5.7 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-336M | $-364M | $-384M | $-313M | $-266M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- Iovance Biotherapeutics (IOVA) steigt um 43% nach starkem Q2. Was als Nächstes kommt.
- Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Small-Cap Stocks to Buy Now?
- Chardan senkt Zielkurs für Iovance (IOVA), behält Buy-Bewertung
- Iovance Biotherapeutics Q1 Earnings Call Highlights
- Analyst Sentiment Remains Strong on Iovance Biotherapeutics (IOVA) Amid U.S. Rollout of Melanoma Drug, Amtagvi
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 316 Einreicher · $915.1M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 49 (-15 vs. Vorquartal) | 35 (0 vs. Vorquartal) | 124 (+7 vs. Vorquartal) | 62 (-4 vs. Vorquartal) | +44.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| MHR FUND MANAGEMENT LLC | $120.503.148 | 28.967.103 | 13,17% | Aktien |
| STATE STREET CORP | $101.829.595 | 24.478.268 | 11,13% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $79.084.500 | 19.010.697 | 8,64% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $75.729.672 | 18.204.248 | 8,28% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $59.858.236 | 14.388.999 | 6,54% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $36.971.836 | 8.885.825 | 4,04% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $35.467.823 | 8.525.919 | 3,88% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $24.866.629 | 5.977.555 | 2,72% | Aktien |
| Palo Alto Investors LP | $22.032.229 | 5.296.209 | 2,41% | Aktien |
| BANK OF AMERICA CORP /DE/ | $19.240.719 | 4.625.173 | 2,10% | Aktien |
| JUPITER ASSET MANAGEMENT LTD | $18.865.933 | 4.535.080 | 2,06% | Aktien |
| JANE STREET GROUP, LLC | $17.758.903 | 4.268.967 | 1,94% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13.393.769 | 3.219.656 | 1,46% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.097.216 | 2.667.600 | 1,21% | Kaufoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.052.038 | 2.656.740 | 1,21% | Aktien |
| GOLDMAN SACHS GROUP INC | $10.683.579 | 2.568.168 | 1,17% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $10.578.372 | 2.542.878 | 1,16% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9.953.632 | 2.392.700 | 1,09% | Verkaufsoption |
| D. E. Shaw & Co., Inc. | $8.915.437 | 2.143.134 | 0,97% | Aktien |
| CITADEL ADVISORS LLC | $8.756.758 | 2.104.990 | 0,96% | Aktien |
| Long Focus Capital Management, LLC | $8.736.000 | 2.100.000 | 0,95% | Aktien |
| Orion Investment Co | $8.624.520 | 2.073.202 | 0,94% | Aktien |
| TWO SIGMA ADVISERS, LP | $8.230.950 | 3.015.000 | 0,90% | Aktien |
| Xcelsior Advisor Partners LLC | $7.421.124 | 1.783.924 | 0,81% | Aktien |
| Rhenman & Partners Asset Management AB | $7.094.160 | 1.705.327 | 0,78% | Aktien |
| Knott David M Jr | $6.656.000 | 1.600.000 | 0,73% | Aktien |
| RICE HALL JAMES & ASSOCIATES, LLC | $6.405.734 | 1.539.840 | 0,70% | Aktien |
| B Group, Inc. | $6.240.000 | 1.500.000 | 0,68% | Aktien |
| Invenomic Capital Management LP | $6.167.595 | 1.482.595 | 0,67% | Aktien |
| WELLS FARGO & COMPANY/MN | $5.994.285 | 1.440.934 | 0,66% | Aktien |
| VANGUARD GROUP INC | $5.760.305 | 2.110.002 | 0,63% | Aktien |
| Woodline Partners LP | $5.671.020 | 1.363.226 | 0,62% | Aktien |
| FMR LLC | $5.629.570 | 1.353.262 | 0,62% | Aktien |
| JPMORGAN CHASE & CO | $4.919.364 | 1.168.495 | 0,54% | Aktien |
| Mirador Capital Partners LP | $4.493.998 | 1.080.288 | 0,49% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $4.391.217 | 1.055.581 | 0,48% | Aktien |
| SECTOR GAMMA AS | $4.028.819 | 968.466 | 0,44% | Aktien |
| CITIGROUP INC | $3.574.126 | 859.165 | 0,39% | Aktien |
| CITADEL ADVISORS LLC | $3.385.824 | 813.900 | 0,37% | Kaufoption |
| BlackRock, Inc. | $3.047.371 | 732.541 | 0,33% | Aktien |
| JANE STREET GROUP, LLC | $3.037.216 | 730.100 | 0,33% | Kaufoption |
| CITADEL ADVISORS LLC | $2.996.864 | 720.400 | 0,33% | Verkaufsoption |
| Swiss National Bank | $2.922.633 | 702.556 | 0,32% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2.862.637 | 688.134 | 0,31% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $2.848.240 | 684.673 | 0,31% | Aktien |
| QVT Financial LP | $2.822.826 | 678.564 | 0,31% | Aktien |
| LPL Financial LLC | $2.750.070 | 661.075 | 0,30% | Aktien |
| 683 Capital Management, LLC | $2.680.288 | 644.300 | 0,29% | Verkaufsoption |
| RHUMBLINE ADVISERS | $2.471.712 | 594.164 | 0,27% | Aktien |
| Mariner, LLC | $2.101.647 | 505.190 | 0,23% | Aktien |
| ALGERT GLOBAL LLC | $1.975.746 | 474.939 | 0,22% | Aktien |
| CM Management, LLC | $1.872.000 | 450.000 | 0,20% | Aktien |
| Bank of New York Mellon Corp | $1.855.065 | 445.929 | 0,20% | Aktien |
| Rafferty Asset Management, LLC | $1.675.981 | 402.880 | 0,18% | Aktien |
| Raiffeisen Bank International AG | $1.599.800 | 380.000 | 0,17% | Aktien |
| Cresset Asset Management, LLC | $1.596.550 | 383.786 | 0,17% | Aktien |
| Balyasny Asset Management L.P. | $1.552.861 | 373.284 | 0,17% | Aktien |
| CORSAIR CAPITAL MANAGEMENT, L.P. | $1.539.200 | 370.000 | 0,17% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $1.477.850 | 421.040 | 0,16% | Aktien |
| JANE STREET GROUP, LLC | $1.436.032 | 345.200 | 0,16% | Verkaufsoption |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $1.420.778 | 404.780 | 0,16% | Aktien |
| Squarepoint Ops LLC | $1.354.421 | 325.582 | 0,15% | Aktien |
| Kennondale Capital Management LLC | $1.323.662 | 318.188 | 0,14% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $1.222.994 | 293.989 | 0,13% | Aktien |
| IEQ CAPITAL, LLC | $1.218.722 | 292.962 | 0,13% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.186.078 | 285.115 | 0,13% | Aktien |
| Virtus Investment Advisers, LLC | $1.185.683 | 285.020 | 0,13% | Aktien |
| Creative Planning | $1.171.914 | 281.710 | 0,13% | Aktien |
| Quadrature Capital Ltd | $1.160.378 | 278.937 | 0,13% | Aktien |
| MORGAN STANLEY | $1.142.544 | 274.650 | 0,12% | Aktien |
| ExodusPoint Capital Management, LP | $1.125.925 | 270.655 | 0,12% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.090.532 | 262.147 | 0,12% | Aktien |
| Man Group plc | $1.052.309 | 252.959 | 0,11% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.036.826 | 295.392 | 0,11% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.025.353 | 246.479 | 0,11% | Aktien |
| TD Asset Management Inc | $1.019.416 | 245.052 | 0,11% | Aktien |
| GROUP ONE TRADING LLC | $988.711 | 237.671 | 0,11% | Aktien |
| MetLife Investment Management, LLC | $965.748 | 232.151 | 0,11% | Aktien |
| UBS Group AG | $952.890 | 229.060 | 0,10% | Aktien |
| Baird Financial Group, Inc. | $924.934 | 222.340 | 0,10% | Aktien |
| Walleye Capital LLC | $923.104 | 221.900 | 0,10% | Kaufoption |
| Vanguard Global Advisers, LLC | $900.228 | 216.401 | 0,10% | Aktien |
| PROFUND ADVISORS LLC | $849.530 | 204.214 | 0,09% | Aktien |
| Parametrica Management Ltd | $814.852 | 195.878 | 0,09% | Aktien |
| Engineers Gate Manager LP | $790.546 | 190.035 | 0,09% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $762.349 | 183.257 | 0,08% | Aktien |
| Invesco Ltd. | $657.292 | 158.003 | 0,07% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $646.872 | 155.498 | 0,07% | Aktien |
| OSAIC HOLDINGS, INC. | $635.207 | 152.695 | 0,07% | Aktien |
| Intellectus Partners, LLC | $631.677 | 151.846 | 0,07% | Aktien |
| Leonteq Securities AG | $624.000 | 150.000 | 0,07% | Aktien |
| Soleus Capital Management, L.P. | $624.000 | 150.000 | 0,07% | Aktien |
| ADAR1 Capital Management, LLC | $607.734 | 146.090 | 0,07% | Aktien |
| Headlands Technologies LLC | $577.570 | 138.839 | 0,06% | Aktien |
| Sugar Maple Asset Management, LLC | $561.600 | 135.000 | 0,06% | Aktien |
| PORTLAND INVESTMENT COUNSEL INC. | $540.800 | 130.000 | 0,06% | Aktien |
| SIMPLEX TRADING, LLC | $524.605 | 126.107 | 0,06% | Aktien |
| JANUS HENDERSON GROUP PLC | $497.977 | 141.672 | 0,05% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $488.292 | 117.378 | 0,05% | Aktien |
| BARCLAYS PLC | $482.759 | 116.048 | 0,05% | Aktien |
Unternehmensinsider 37 Insider · 9 Führungskräfte · 14 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Frederick G Vogt | Interim CEO & General Counsel | 5. Juni 2026 M | 562.492 | 0 | 0 | $0 |
| Maria Fardis | President and CEO | 4. Januar 2021 A | 298.786 | 0 | 0 | $0 |
| Paul Kessler | Chair,CEO, Pres., Pr.Acctg | 24. Juli 2013 A | 15.693.215 | 0 | 0 | $0 |
| Jean-Marc Bellemin | Chief Financial Officer | 2. Juni 2025 M | 60.529 | 0 | 0 | $0 |
| Timothy E Morris | Chief Financial Officer | 4. März 2019 A | — | 0 | 0 | $0 |
| Igor Bilinsky | Chief Operating Officer | 5. Juni 2026 M | 133.920 | 0 | 0 | $0 |
| Raj K. Puri | Chief Regulatory Officer | 16. Juni 2026 A | 248.114 | 0 | 0 | $0 |
| Finckenstein Friedrich Graf | Chief Medical Officer | 5. Juni 2026 M | 140.111 | 0 | 0 | $0 |
| Michael Swartzburg | Vice President, Finance (PAO) | 4. Januar 2021 A | — | 0 | 0 | $0 |
| Iain D. Dukes | Direktor | 16. Juni 2026 A | 54.000 | 0 | 0 | $0 |
| Athena Countouriotis | Direktor | 16. Juni 2026 A | — | 0 | 0 | $0 |
| Ryan D Maynard | Direktor | 16. Juni 2026 A | 7.500 | 0 | 0 | $0 |
| Michael Weiser | Direktor | 16. Juni 2026 A | 112.632 | 0 | 0 | $0 |
| Wendy L Yarno | Direktor | 13. Juni 2025 A | — | 0 | 0 | $0 |
| Wayne P. Rothbaum | Direktor | 1. März 2024 A | 28.067.333 | 0 | 0 | $0 |
| Merrill A Mcpeak | Direktor | 1. März 2024 A | 320.150 | 0 | 0 | $0 |
| Wendy L Dixon | Direktor | 10. Juni 2022 A | — | 0 | 0 | $0 |
| Ayer Capital Management, LP | Direktor | 22. Mai 2013 C | 560.401.150 | 0 | 0 | $0 |
| Martin Schroeder | Direktor | 22. August 2011 P | 1.000.000 | 0 | 0 | $0 |
| Mark J Ahn | Direktor | 26. Mai 2010 A | — | 0 | 0 | $0 |
| Bristol Investment Fund, Ltd. | 10%-Eigentümer | 6. November 2014 S | 3.867.863 | 0 | 0 | $0 |
| Hamilton Atlantic | 10%-Eigentümer | 31. März 2010 J | 0 | 0 | 0 | $0 |
| Daniel Gordon Kirby | — | 10. August 2026 M | 154.511 | 0 | 0 | $0 |
| Corleen M. Roche | — | 6. August 2026 M | 28.757 | 0 | 0 | $0 |
| Jay Venkatesan | — | 1. Juni 2017 A | — | 0 | 0 | $0 |
| Sanford Hillsberg | — | 1. Juni 2017 A | 100.000 | 0 | 0 | $0 |
| Gregory T Schiffman | — | 14. November 2016 A | — | 0 | 0 | $0 |
| Molly Henderson | — | 10. Juni 2016 A | — | 0 | 0 | $0 |
| Michael Lotze | — | 28. März 2016 A | — | 0 | 0 | $0 |
| James G. Bender | — | 11. März 2016 A | 88.726 | 0 | 0 | $0 |
| Elma Hawkins | — | 11. März 2016 A | 176.567 | 0 | 0 | $0 |
| Steven A. Fischkoff | — | 4. Februar 2016 A | — | 0 | 0 | $0 |
| Laszlo Radvanyi | — | 5. Dezember 2014 A | 180.000 | 0 | 0 | $0 |
| Michael D Handelman | — | 5. Dezember 2014 A | — | 0 | 0 | $0 |
| Manish Singh | — | 30. Dezember 2013 A | 2.546.000 | 0 | 0 | $0 |
| Richard Mckilligan | — | 29. März 2011 J | 1.220.016 | 0 | 0 | $0 |
| Robert T. Brooke | — | 25. März 2011 J | 4.440.008 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 6 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Quogue Capital LLC, Wayne P. Rothbaum ×5 Einreichungen | 19. März 2024 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 11. Februar 2015 | — | Erste Einreichung | — | SEC |
| Bristol Investment Fund, Ltd., Bristol Capital, LLC ×4 Einreichungen | 20. Februar 2014 | — | Erste Einreichung | — | SEC |
| Robert T. Brooke ×2 Einreichungen | 12. Mai 2011 | — | Erste Einreichung | — | SEC |
| Hamilton Atlantic | 5. November 2010 | — | Erste Einreichung | M&A / Verkauf | SEC |
| Nicht offengelegter meldender Beteiligter | 29. März 2010 | — | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 49 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IDNA · iShares Trust | 2,65% | 841.830 SH | 8. August 2026 | Täglich |
| BBP · ETFis Series Trust I | 2,44% | 430.167 NS | 30. April 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,77% | 27.306 SH | 8. August 2026 | Täglich |
| CANC · Tema ETF Trust | 0,65% | 280.048 NS | 31. Mai 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,30% | 466.051 NS | 30. April 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,23% | 1.035.381 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,19% | 24.302 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,19% | 2.852.725 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,16% | 3.686.426 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,11% | 346.628 SH | 8. August 2026 | Täglich |
| GINN · Goldman Sachs ETF Trust | 0,09% | 45.126 NS | 31. Mai 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,09% | 6.714 NS | 31. Mai 2026 | N-PORT |
| BIB · ProShares Trust | 0,08% | 15.232 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,08% | 10.143.030 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,07% | 76.919 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,07% | 452.513 NS | 31. Mai 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 261.797 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 2.290.247 SH | 8. August 2026 | Täglich |
| TECB · iShares Trust | 0,05% | 38.134 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,04% | 1.472.303 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 15.876 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 146.249 NS | 30. April 2026 | N-PORT |
| ISCB · iShares Trust | 0,03% | 15.580 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 1.615.534 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 12.416 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 4.303.944 SH | 8. August 2026 | Täglich |
| VBR · VANGUARD INDEX FUNDS | 0,02% | 3.089.380 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 1.053.780 SH | 8. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 21.537 SH | 8. August 2026 | Täglich |
| TMFE · RBB Fund, Inc. | 0,02% | 3.704 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 140.923 NS | 30. April 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 18.065 NS | 30. April 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 12.558 NS | 31. Mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 71.148 NS | 30. April 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,01% | 4.849.607 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 12.045 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 315 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 44.207 NS | 30. April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 125.344 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 146.278 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 482.457 NS | 30. April 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 510.986 SH | 8. August 2026 | Täglich |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 89.379 NS | 31. Mai 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 16.834 NS | 30. April 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 128.547 NS | 30. April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 224.829 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 64.557 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 13.489.795 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 32.806 SH | 8. August 2026 | Täglich |